Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Equine Vet J ; 43(5): 543-51, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21496086

ABSTRACT

REASONS FOR PERFORMING STUDY: Abnormal epidermal stem cell regulation may contribute to the pathogenesis of equine chronic laminitis. OBJECTIVE: To analyse the involvement of p63, a regulator of epidermal stem cell proliferative potential, in chronic laminitis. METHODS: Epidermal tissues from skin, coronet and lamellae of the dorsal foot were harvested from 5 horses with chronic laminitis and 5 control horses. Tissues were analysed using histopathology, immunofluorescence microscopy and quantitative immunoblotting. RESULTS: Hoof lamellae of laminitic horses had a lower frequency of p63 positive cells than control lamellae, particularly in the distal region. Quantitative immunoblotting confirmed reduced p63 expression in the laminitic distal lamellar region. The decreased p63 expression in laminitic epidermal lamellae was most apparent in the abaxial region adjacent to the hoof wall and highly associated with the formation of terminally differentiated, dysplastic and hyperkeratotic epidermis in this region, whereas lamellae from control horses maintained high p63 expression throughout the axial-abaxial axis. CONCLUSIONS: Expression of p63 in equine skin resembles that reported in other species, including man and rodents, suggesting that p63 can serve as a marker for the proliferative potential of equine epidermal stem cells. p63 expression was significantly lower in the chronic laminitic hoof than in that of control horses, suggesting laminitic hoof epithelium has more limited proliferative potential with a shift towards differentiation. This may reflect reduced activity of epidermal stem cells in laminitic hoof. It is proposed that p63 contributes to the maintenance of hoof lamellae and that misregulation of p63 expression may lead to epidermal dysplasia during lamellar wedge formation. POTENTIAL RELEVANCE: This study suggests that loss of epidermal stem cells contributes to the pathogenesis of equine laminitis. Autologous transplantation of p63-positive epidermal stem cells from unaffected regions may have regenerative therapeutic potential for laminitic horses.


Subject(s)
Foot Diseases/veterinary , Gene Expression Regulation , Hoof and Claw/metabolism , Horse Diseases/metabolism , Inflammation/veterinary , Tumor Suppressor Proteins/metabolism , Animals , Chronic Disease , Female , Foot Diseases/metabolism , Horses , Inflammation/metabolism , Male , Tumor Suppressor Proteins/genetics
2.
Int Immunol ; 13(11): 1405-14, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11675372

ABSTRACT

We have generated mutant mice in which TCR beta chain enhancer (E(beta)) was replaced with the TCR alpha chain enhancer (E(alpha)). Using this mouse model, we analyzed (i) recombination status of the TCR beta chain genes after functional V(D)J rearrangements occurred in the first allele during double-negative (DN)-to-double-positive (DP) transition and (ii) involvement of E(beta) for the expression of rearranged TCR beta chain genes. Our data show that E(alpha) substituted for E(beta) function to express a similar extent of TCR beta chains exactly at the same time as did E(beta) (CD25+CD44- DN stage), although the proportion of TCR beta+ cells at this stage was low in mutant mice. At the DP stage, germline transcription and histone acetylation of D(beta)-J(beta) loci were detectable at a high degree in both mutant and wild-type mice. However, DP cells in mutant mice retained the germline D(beta)-J(beta) configuration at a higher frequency than that of wild-type mice, whereas both DP cells expressed TCR beta chains to a similar extent. These data suggest that chromatin opening has a limited impact on D(beta)-to-J(beta) recombination at the DP stage and that E(alpha) is functionally equivalent to E(beta) in promoting expression of functionally rearranged TCR beta chain genes through DN-to-DP transition.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Chromatin/physiology , Receptors, Antigen, T-Cell, alpha-beta/genetics , Thymus Gland/immunology , Animals , Enhancer Elements, Genetic , Germ-Line Mutation , Mice , Mice, Mutant Strains , Recombination, Genetic
3.
J Biol Chem ; 276(45): 41717-24, 2001 Nov 09.
Article in English | MEDLINE | ID: mdl-11546792

ABSTRACT

Tumor suppressor p53 has been shown to transactivate epidermal growth factor receptor (EGFR) expression through binding to a putative p53 responsive element in the EGFR promoter between nucleotides -265 and -239 (EGFRp53RE). Isotypes of p63 gene products, recently identified as p53 relatives, have a similar function to transactivate several p53 target gene promoters. However, our results indicate that TAp63gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and endogenous EGFR expression. Transient transfection assays show that the EGFR promoter region between -348 and -293, containing two Sp1 sites, is crucial for the repression of the EGFR expression by TAp63gamma. Mutations in these Sp1 sites in the reporter constructs result in loss of the TAp63gamma repression effect. We further show that TAp63gamma directly interacts with Sp1 by immunoprecipitation analysis and that TAp63gamma impairs Sp1 binding to the target DNA site in electrophoretic mobility shift assays. These results suggest that TAp63gamma is involved in the regulation of the EGFR gene expression through interactions with basal transcription factors.


Subject(s)
ErbB Receptors/genetics , Membrane Proteins , Phosphoproteins/physiology , Repressor Proteins/physiology , Trans-Activators/physiology , DNA/metabolism , DNA-Binding Proteins , Genes, Tumor Suppressor , Humans , Promoter Regions, Genetic , RNA, Messenger/analysis , Response Elements , Sp1 Transcription Factor/metabolism , Transcription Factors , Tumor Cells, Cultured , Tumor Suppressor Proteins
4.
Biochem Biophys Res Commun ; 286(3): 628-34, 2001 Aug 24.
Article in English | MEDLINE | ID: mdl-11511106

ABSTRACT

The p51/p73L/p63/p40 gene, recently identified as a p53 homolog, encodes two major isoforms, p51A and p73L, which are suggested to have similar functions synonymous with p53 and dominant-negative activity toward both p53 and p51A, respectively. We have cloned a high affinity genomic fragment bound to p51A that was assigned to be a novel retrovirus long terminal repeat. Strikingly, this fragment was found to bind to both p53 and p73L with similar affinity to p51A. Additional demonstration with known p53 response elements suggested that DNA-binding profiles of p51A and p73L were very similar but were distinct from that of p53. Consistent with this novel finding, transient cotransfection experiments in mammalian cells suggested that p73L, when it was expressed at a low level, selectively suppressed p53-dependent transactivation of p21-luc and mdm2-luc but not of cyclinG-luc and bax-luc reporters. These data raise the possibility that p73L differentially modulates the p53 function according to the distinct DNA-binding affinity between these two proteins.


Subject(s)
DNA-Binding Proteins/metabolism , DNA-Binding Proteins/physiology , Nuclear Proteins/physiology , Phosphoproteins , Retroviridae/genetics , Terminal Repeat Sequences , Trans-Activators , Tumor Suppressor Protein p53/physiology , Animals , Base Sequence , Binding Sites , Cloning, Molecular , Consensus Sequence , DNA-Binding Proteins/genetics , Genes, Tumor Suppressor , Mice , Molecular Sequence Data , Mutation , Nuclear Proteins/genetics , Promoter Regions, Genetic , Transcription Factors , Tumor Protein p73 , Tumor Suppressor Proteins
5.
Br J Cancer ; 84(9): 1235-41, 2001 May 04.
Article in English | MEDLINE | ID: mdl-11336476

ABSTRACT

We have recently identified a second p53 -related p73L gene, also referred to as p63 / p51 / p40 / KET gene, which encodes the 2 major isoforms p73L and p51 resulting from different exon usage at their amino terminal regions. Although p73L and p51 are suspected to play oncogenic and tumour suppressive roles in mammalian cells, respectively, no evidence of linkage between the expression of these isoforms and human cancers has been reported so far. In this study, we first investigated the expression profile of p51 and p73L in various human tumour cell lines and found that a novel isoform, termed DeltaNp73L, was predominantly expressed in squamous cell carcinomas. The expression profile of DeltaNp73L/p73L/p51 in primary human skin cancer specimens showed that the expression of p51 was frequently lost (62%) but was detected in all normal skin samples. In p51-expressing skin cancers, DeltaNp73L expression was associated at a high frequency (75%) though it was not detected in normal skin tissues. Transient co-transfection data indicate the possibility that DeltaNp73L can inhibit p53-, and more preferentially, p51-mediated transactivation. These data suggest that the loss of expression of p51 and/or the expression of DeltaNp73L might contribute to the pathogenesis of human squamous cell carcinomas.


Subject(s)
Carcinoma, Squamous Cell/genetics , DNA-Binding Proteins/biosynthesis , Gene Expression Regulation, Neoplastic , Membrane Proteins , Nuclear Proteins/biosynthesis , Phosphoproteins/biosynthesis , Proteins , Skin Neoplasms/genetics , Trans-Activators , Tumor Suppressor Protein p53/biosynthesis , Carcinoma, Squamous Cell/physiopathology , Cell Line , DNA-Binding Proteins/genetics , Genes, Tumor Suppressor , Humans , NADPH Oxidases , Nuclear Proteins/genetics , Phosphoproteins/genetics , Skin Neoplasms/physiopathology , Transcription Factors , Transcription, Genetic , Tumor Protein p73 , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Proteins
6.
Mol Genet Metab ; 69(4): 269-76, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10870844

ABSTRACT

Fetal somatic cell gene therapy could become an attractive solution for some congenital genetic diseases or the disorders which manifest themselves during the fetal period. We performed adenovirus-mediated gene transfer to mice and guinea pig fetuses in utero and evaluated the efficiency of gene transfer by histochemical analysis and a quantitative TaqMan-polymerase chain reaction (TaqMan-PCR) assay. We first injected a replication-deficient recombinant adenovirus containing the Escherichia coli LacZ gene driven by a CAG promoter (AxCALacZ) into pregnant mice through the amniotic space, placenta, or intraperitoneal space of the fetus. Histochemical analysis showed limited transgene expression in fetal tissues. We then administered AxCALacZ to guinea pig fetuses in the late stage of pregnancy through the umbilical vein. The highest beta-galactosidase expression was observed in liver followed by moderate expression in heart, spleen, and adrenal gland. The transgene expression was also present in kidney, intestine, and placenta to a lesser degree. No positively stained cells were observed in lung, muscle, or pancreas except in the vascular endothelium of these organs. Quantitative measurement of recombinant adenoviral DNA by the TaqMan-PCR assay showed that the vast majority of the injected viruses was present in liver. The current study indicated that adenovirus-mediated gene transfer into guinea pig fetus through the umbilical vein is feasible and results in efficient transgene expression in fetal tissues. The experimental procedures using pregnant guinea pigs might serve as a good experimental model for in utero gene transfer. Since our TaqMan-PCR assay detects the LacZ gene, one of the most widely used reporter genes, it may be generally applicable to adenovirus quantification in various gene transfer experiments.


Subject(s)
Adenoviridae/genetics , Fetus/metabolism , Gene Transfer Techniques , Animals , Cell Line , DNA Probes , DNA, Recombinant/genetics , DNA, Recombinant/metabolism , Female , Guinea Pigs , Humans , Lac Operon/genetics , Mice , Mice, Inbred ICR , Polymerase Chain Reaction/methods , Pregnancy , Taq Polymerase , Tissue Distribution , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
7.
Obstet Gynecol ; 95(5): 656-61, 2000 May.
Article in English | MEDLINE | ID: mdl-10775724

ABSTRACT

OBJECTIVE: To determine differences between growth patterns of monochorionic and dichorionic twins, and of concordant and discordant twins of both chorionicities. METHODS: We studied 70 cases of concordant twins (24 monochorionic, 46 dichorionic) and 45 cases of discordant twins (25 monochorionic, 20 dichorionic). In each case, growth was measured longitudinally by ultrasound biometry and the growth pattern was depicted. RESULTS: There were no differences in incremental growth between concordant monochorionic and dichorionic twins. The growth curve of concordant twins of both chorionicities was almost the same as that of a singleton until 34 weeks' gestation. However, in the discordant twins, the growth of the larger twin matched the growth curve of a singleton or concordant twin, but the growth of the smaller twin gradually decreased to the range of growth restriction. The growth curves for monochorionic discordant twins appeared to be representative of two groups, one of which had onset of discordancy before 24 weeks. CONCLUSION: It is clinically important to determine chorionicity early in twin pregnancies, to calculate the percentage of discordancy between the fetuses, and to examine longitudinal fetal growth curves in each chorionicity.


Subject(s)
Chorion/diagnostic imaging , Embryonic and Fetal Development , Pregnancy, Multiple/physiology , Ultrasonography, Prenatal , Biometry , Female , Humans , Pregnancy , Twins , Ultrasonography, Prenatal/methods
8.
Int J Oncol ; 15(6): 1149-53, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10568821

ABSTRACT

Genetic mutation of p53, which monitors DNA damage and operates cellular checkpoints, is a major factor in the development of human malignancies. A novel gene p63/p73L/p51, encoding a protein with significant homology to p53 and p73, was recently identified at 3q27-9. To investigate the penetration of p63 in cervical carcinogenesis, mutation and transcription analyses of p63 were performed in cervical carcinoma. A certain isotype of p63 called TAp63gamma encodes the acidic N-terminus and possesses a short C-terminus. Using reverse transcriptase-polymerase chain reaction-single strand conformation polymorphism (RT-PCR-SSCP) analysis for TAp63gamma, one mutation was found in the cervical carcinoma cell line SKG-I. However, no mutations causing amino acid substitutions or frameshifts were found in 54 cases examined for TAp63gamma, which is thought to be a tumor suppressor gene. While cervical carcinomas tended to yield a positive signal in the RT-PCR reaction designed to amplify transcripts encoding the acidic N-terminus, normal cervix and cervical intraepithelial neoplasia (CIN) did not express this transcript. These data suggest that the p63 gene does not play an essential role as a tumor suppressor gene, but expression of TAp63gamma may be speculatively associated with tumor growth in cervical carcinogenesis.


Subject(s)
Genes, Tumor Suppressor/genetics , Membrane Proteins , Phosphoproteins/genetics , Trans-Activators , Uterine Cervical Neoplasms/genetics , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Adult , Aged , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , DNA-Binding Proteins , Female , Gene Expression Regulation, Neoplastic , HeLa Cells , Humans , Middle Aged , Mutation , Protein Isoforms/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription Factors , Transcription, Genetic , Tumor Cells, Cultured , Tumor Suppressor Proteins , Uterine Cervical Neoplasms/pathology
9.
Tohoku J Exp Med ; 187(3): 263-72, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10458483

ABSTRACT

We analyzed the androgen receptor (AR) gene in five Japanese patients diagnosed with androgen insensitivity syndrome (AIS). All AR genes from the five patients had single-nucleotide substitutions, which introduced a premature termination codon in three patients (Gln640, Arg752, and Gln640 and Trp751), and a single amino acid substitution in two patients (Arg831 to Gln, and Leu812 to Phe). All the mutations occurred in the steroid-binding domain, comprising exons D through G. The three patients with the premature termination codon(s) and the one patient with Arg831Gln were clinically diagnosed as having complete AIS, while the patient with Leu812Phe had a partial form of AIS. Pubic skin fibroblasts from four of the five patients did not show detectable androgen binding. These data on mutations that have not been reported previously, provide valuable information for the further characterization of structural and functional relationships in the steroid-binding domain of the AR protein.


Subject(s)
Androgen-Insensitivity Syndrome/genetics , Point Mutation , Receptors, Androgen/genetics , Adult , Asian People , Binding Sites/genetics , Humans , Japan , Male , Middle Aged
10.
Pediatr Res ; 45(4 Pt 1): 465-73, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10203136

ABSTRACT

Phenylketonuria (PKU) is caused by deficiency of phenylalanine hydroxylase (PAH) in the liver. Patients with PKU show increased L-phenylalanine in blood, which leads to mental retardation and hypopigmentation of skin and hair. As a step toward gene therapy for PKU, we constructed a replication-defective, E1/E3-deleted recombinant adenovirus harboring human PAH cDNA under the control of a potent CAG promoter. When a solution containing 1.2 x 10(9) plaque-forming units of the recombinant adenovirus was infused into tail veins of PKU model mice (Pah(enu2)), predominant expression of PAH activity was observed in the liver. The gene transfer normalized the serum phenylalanine level within 24 h. However, it also provoked a profound host immune response against the recombinant virus; as a consequence, the biochemical changes lasted for only 10 d and rechallenge with the virus failed to reduce the serum phenylalanine concentration. Administration of an immunosuppressant, FK506, to mice successfully blocked the host immune response, prolonged the duration of gene expression to more than 35 d, and allowed repeated gene delivery. We noted a change in coat pigmentation from grayish to black after gene delivery. The current study is the first to demonstrate the reversal of hypopigmentation, one of the major clinical phenotypes of PKU in mice as well as in humans, by adenovirus-mediated gene transfer, suggesting the feasibility of gene therapy for PKU.


Subject(s)
Genetic Therapy/methods , Hypopigmentation/etiology , Hypopigmentation/therapy , Phenylalanine Hydroxylase/genetics , Phenylketonurias/therapy , Transfection/methods , Adenoviridae , Animals , COS Cells , Gene Transfer Techniques , Genetic Vectors , Humans , Liver/drug effects , Liver/pathology , Mice , Mice, Mutant Strains , Phenylalanine/blood , Phenylalanine Hydroxylase/deficiency , Phenylalanine Hydroxylase/metabolism , Phenylketonurias/physiopathology , Recombinant Proteins/metabolism , Tacrolimus/pharmacology , Time Factors
11.
Biochem Biophys Res Commun ; 248(3): 603-7, 1998 Jul 30.
Article in English | MEDLINE | ID: mdl-9703973

ABSTRACT

The p53 protein, which regulates the rate of cell division and death, is the most frequently mutated tumor suppressor to be identified so far in human cancers. Recently, a gene with significant homology to p53, termed p73, has been identified in a chromosomal region that is implicated in the molecular pathogenesis of neuroblastoma. We have cloned a second human p53-related gene, termed p73L, which shows strong amino-acid similarity to p73. The p73L gene is mapped to human chromosome 3q27-28 using in situ hybridization technique. p73L encodes a protein of 586 amino acids and its putative DNA binding domain (DBD) has high identities to those of p53 (60.6%) and to p73 (87.8%). Northern blot analysis, which demonstrated that the expression profiles of p73L and p73 mRNAs are distinct in some tissues, implies that p73 and p73L may have separate, distinct roles in different tissues.


Subject(s)
Chromosomes, Human, Pair 3 , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/chemistry , Genes, Tumor Suppressor , Nuclear Proteins/biosynthesis , Nuclear Proteins/chemistry , Amino Acid Sequence , Animals , Chromosome Mapping , DNA-Binding Proteins/genetics , Humans , Mice , Molecular Sequence Data , Molecular Weight , Nuclear Proteins/genetics , Organ Specificity , Phosphoproteins , Protein Biosynthesis , Sequence Alignment , Sequence Homology, Amino Acid , Trans-Activators , Transcription Factors , Transcription, Genetic , Tumor Protein p73 , Tumor Suppressor Proteins
12.
J Hum Genet ; 43(2): 85-90, 1998.
Article in English | MEDLINE | ID: mdl-9621511

ABSTRACT

The aim of this study was to calculate the expected incidences of chromosome abnormalities found at amniocentesis in Japanese women aged 35 and older. From four clinics in Japan, we gathered genetic amniocentesis data on 5484 pregnant women at risk only due to their advanced age, 35 years and older. We analyzed the data using the logistic regression model. Of the 5484 fetuses, 117 (2.1%) were diagnosed with a chromosome abnormality. The abnormal karyotypes included 42 cases of trisomy 21; 13 of trisomy 18; 7 of trisomy 13; 10 of 47,XXY; 4 of 47,XXX; 1 of 47,XYY; 27 with various structural aberrations; and 13 with various types of mosaicism. The incidences of trisomy 21, lethal autosomal aneuploidies (trisomy 18 and trisomy 13), and sex-chromosome abnormalities (XXY, XXX, XYY) increased with maternal age. Parameters of the regression equations with their standard errors were calculated and the expected incidences of chromosome abnormalities at each maternal age were derived. The expected incidences of chromosome abnormalities obtained in this study are the first data published for Japan and will be useful for the counseling of pregnant women. The incidence of trisomy 21 is not different from the rates published previously for Western countries. The incidences of chromosome abnormalities are not affected by race or by geographic factors.


Subject(s)
Amniocentesis , Chromosome Aberrations/epidemiology , Fetal Diseases/epidemiology , Maternal Age , Pregnancy, High-Risk , Age Factors , Aneuploidy , Chromosome Aberrations/genetics , Chromosome Disorders , Down Syndrome/epidemiology , Down Syndrome/genetics , Female , Fetal Diseases/genetics , Humans , Incidence , Japan/epidemiology , Logistic Models , Mosaicism , Pregnancy , Risk , Sex Chromosome Aberrations/epidemiology , Sex Chromosome Aberrations/genetics , Trisomy
13.
Int Immunol ; 10(5): 553-60, 1998 May.
Article in English | MEDLINE | ID: mdl-9645603

ABSTRACT

During the thymic development of alphabeta lineage T cells, maturation of the CD4- CD8- double-negative (DN) cells into the CD4+ CD8+ double-positive cells is accompanied by the induction of TCR beta allelic exclusion. Recent studies have shown that these events are regulated by the signals through the pre-TCR complex which consists of the TCR beta, pre-TCR alpha and CD3 components. The Vbeta germline transcripts are detected prior to the TCR beta chain gene rearrangements in the DN thymocytes. To examine the effects of the pre-TCR-mediated signals on Vbeta germline transcription, we analyzed thymocytes from RAG-2-deficient mice treated with anti-CD3epsilon antibody. The germline transcripts of all Vbeta we examined, except for Vbeta14, were down-regulated by the anti-CD3epsilon antibody treatment. These data indicate that the regulation of Vbeta germline transcription by the signals through the pre-TCR complex may reflect the modulation of Vbeta accessibility to the VDJ recombinase, which contributes to TCR beta allelic exclusion.


Subject(s)
CD3 Complex/genetics , DNA-Binding Proteins/metabolism , Receptors, Antigen, T-Cell, alpha-beta/genetics , Alleles , Animals , Base Sequence , DNA Methylation , DNA Nucleotidyltransferases/metabolism , DNA Primers/genetics , DNA-Binding Proteins/genetics , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor , Mice , Mice, Inbred C57BL , Mice, Knockout , Polymerase Chain Reaction , Signal Transduction , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Transcription, Genetic , VDJ Recombinases
14.
Tohoku J Exp Med ; 179(2): 131-9, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8875769

ABSTRACT

To study the fine structure of fragmentary marker chromosomes, we performed scanning electron microscopy (SEM) on samples isolated from two carriers (Case 1: 46, XY/47, XY, +mar/48, XY, +mar, +mar; Case 2: 47, XY, +mar). In both cases, light microscopic observation revealed that marker chromosomes lacked a centromere and were fragmented in appearance. However, SEM observation of the metaphasic cells in both cases showed three variations. One variation was a structure that seemed to be metacentric, another was a structure that seemed to be submetacentric, and the remaining one was essentially fragmentary. However, neither the usual chromatid nor centromere formations were observed in the metacentric-like and submetacentric-like structures, even when both cases were observed by SEM. Moreover, the marker chromosomes of the boy of Case I, who suffered from various clinical troubles, included a greater population of metacentric-like or submetacentric-like structures than of essentially fragmentary structures. The marker chromosomes of the fetus of Case 2, who suffered from no clinical problems, included a much greater population of essentially fragmentary structures than metacentric-like or submetacentric like structures. Therefore, SEM observation of fragmentary marker chromosomes that are visible on light microscopy might be used to define specific structures. Moreover, SEM observation might provide clinical criteria relating to the pathogenesis of fragmentary marker chromosomes found on light microscopy.


Subject(s)
Chromosome Aberrations , Chromosomes, Human/genetics , Chromosomes, Human/ultrastructure , Genetic Markers , Abnormalities, Multiple/genetics , Adult , Chromosome Banding , Female , Humans , Infant , Karyotyping , Male , Microscopy, Electron, Scanning , Mosaicism , Pregnancy , Prenatal Diagnosis
15.
J Cardiol ; 20(3): 571-81, 1990.
Article in Japanese | MEDLINE | ID: mdl-2131347

ABSTRACT

To diagnose and characterize post-infarction left ventricular aneurysms, we performed exercise thallium-201 myocardial single photon emission computed tomography (SPECT) combined with selective coronary angiography and left ventriculography. The subjects consisted of 79 patients with acute myocardial infarction; 42 with anteroseptal, three with both anterior and inferior, 29 with inferior and five with posterior infarction. Visual classification of ventricular wall morphology by either a horizontal or a vertical long-axis image was designed into convergent (C), parallel (P) and divergent (D) types, according to the interrelationship between either septal and lateral wall or anterior and inferior wall, respectively. This method was applied in post-stress and delayed images, and these patients were divided into five groups (Group A-E) in accordance with varying morphological types from the post-stress to the delayed as follows: C-C (Group A, 36 patients), P-C (Group B, 8), P-P (Group C, 7), D-P (Group D, 5) and D-D (Group E, 23). A high incidence (21/23) of a left ventricular aneurysm by left ventriculography was recognized in Group E patients in comparison with other Groups. Provided that either Group D or E (all patients had anterior infarction) had left ventricular aneurysms, the diagnostic sensitivity, specificity and accuracy were 89%, 92% and 86%, respectively. Two of three patients with false negative diagnosis had only apical involvement. Furthermore, these two Groups had significantly larger defect scores as calculated by polar maps than did the other three Groups. When patients with anterior infarction with defect scores of 200 or greater were defined positive, the sensitivity, specificity and accuracy of ventricular aneurysms were 96%, 75% and 86%, respectively. One false negative case was apical infarction, and one of the two false positive cases were extensive anteroseptal infarction involving the apex. These results suggest that a left ventricular aneurysm which is important in predicting prognostic sequence could be diagnosed only by exercise SPECT, and that it could be characterized by extensive and severe apicoanterior infarction and a divergent-type ventricular wall arrangement on a post-stress SPECT image.


Subject(s)
Heart Aneurysm/diagnostic imaging , Heart/diagnostic imaging , Thallium Radioisotopes , Tomography, Emission-Computed, Single-Photon , Exercise Test , Heart Aneurysm/etiology , Heart Ventricles , Humans , Male , Middle Aged , Myocardial Infarction/complications
16.
Am J Med Sci ; 297(4): 247-50, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2539718

ABSTRACT

Patients with latent disorders of hormone response mechanism are rarely found. This paper reports a case of subclinical pseudohypoparathyroidism type II in which physiological adjustment of calcium (Ca) metabolism became insufficient only in the second half of pregnancy. A 34-year-old woman examined for a slight bruise on the head was incidentally found to have marked intracranial calcification and a full set of false teeth. From her history of past pregnancy, it was revealed that she suffered from symptoms of hypocalcemia during late gestation (serum total Ca level, 4.8-6.4 mg/dl), which disappeared spontaneously after delivery. When the woman was not pregnant, although only the total Ca level was slightly below the normal range (7.7-8.4 mg/dl), the serum ionized Ca, phosphorus (P), magnesium, 1,25-dihydroxycholecalciferol and 24,25-hydroxycholecalciferol levels, plasma parathyroid hormone (PTH) level and urinary excretion of Ca were all normal without treatment. Intravenous infusion of 30 mg/kg EDTA-2Na resulted in marked elevation of plasma PTH associated with significant reduction of serum ionized Ca. In contrast, although her urinary excretion of phosphorous per hour was within the normal range in the basal state, she showed no proportional change in urinary phosphorous excretion with increase in urine cyclic AMP induced by administration of PTH(1-34). From these findings, she was diagnosed as having an incomplete form of pseudohypoparathyroidism Type II. This abnormality seems to be rare, but we consider that the present observations provide important information for preventive care of pregnant women and fetuses during gestation.


Subject(s)
Adaptation, Physiological , Calcium/metabolism , Pregnancy Complications/metabolism , Pseudohypoparathyroidism/metabolism , Adult , Brain Diseases, Metabolic/diagnostic imaging , Brain Diseases, Metabolic/etiology , Calcinosis/diagnostic imaging , Calcinosis/etiology , Calcium/physiology , Cyclic AMP/urine , Female , Humans , Parathyroid Hormone/blood , Phosphorus/urine , Pregnancy , Pseudohypoparathyroidism/complications , Tomography, X-Ray Computed
17.
J Cardiol ; 18(4): 935-47, 1988 Dec.
Article in Japanese | MEDLINE | ID: mdl-3267731

ABSTRACT

To evaluate coronary artery disease, a new quantitative thallium-201 (201T1)-tomographic scintigraphic score (TSS: modified Massie's score) using oxygen consumption (METS) was developed and compared with coronary angiographic score (CAG-S) in 27 patients (eight patients with normal coronary angiograms, and five, eight and six patients with one, two and three vessel disease, respectively) without previous myocardial infarction. All patients received both coronary angiography and the treadmill exercise test using 201T1-myocardial single photon emission computed tomography (SPECT) within two weeks. The redistribution area (RA) and washout rate area (WA) were derived from the circumferential profile analysis using apical (A), midventricular (M) and basal (B) short-axis images. To obtain TSS values, the sum of these values was divided both by percentage of the age-predicted maximal heart rate (%PMHR) and the METS value as follows: TSS = [RA (A, M, B) + WA (A, M, B)]/(%PMHR x METS). The results were as follows: 1. TSS values were 6.4 +- 1.6, 9.4 +/- 2.2, 24.2 +/- 12.0 and 30.6 +/- 5.0 (mean +/- SD) in normal, one, two and three vessel disease groups, respectively. Significant differences were found among each group except between two and three vessel disease groups. 2. The detectability of significant coronary artery disease was 89% (17/19) except in two patients with one vessel disease. 3. A high correlation coefficient was found between TSS (X) and CAG-S (Y), i.e., Y = 0.8X - 3.5 (r = 0.944, p less than 0.001). It was concluded that the tomographic scintigraphic score (TSS) is useful not only for detecting, multivessel disease but also for totally-evaluating its severity, extent and influence on collateral supply, and could be used for analyzing prognosis and the selection of therapeutic interventions.


Subject(s)
Coronary Disease/diagnostic imaging , Thallium Radioisotopes , Tomography, Emission-Computed, Single-Photon , Aged , Coronary Angiography , Coronary Disease/metabolism , Exercise Test , Female , Humans , Male , Middle Aged , Myocardium/metabolism , Oxygen Consumption
19.
Microbiol Immunol ; 31(11): 1131-5, 1987.
Article in English | MEDLINE | ID: mdl-2451112

ABSTRACT

Neuraminidases of 18 strains of avian influenza A virus were examined by both colorimetric and fluorometric assays using fetuin and 4-methylumbelliferyl-N-Ac-alpha-D-neuraminide as substrates, respectively, to compare them with those of human influenza A and B viruses. The ratios of the neuraminidase activity of avian influenza virus measured by the colorimetric assay method to that measured by the fluorometric assay were distributed in the range of 2.4-20.3. The enzyme of avian influenza virus showed calcium-ion dependence in both assay methods. These results suggest that neuraminidase of avian influenza A virus is varies greatly from one strain to another in substrate specificity as compared with those of human influenza A and B viruses, and that some strains of avian influenza A virus have a neuraminidase with unique enzymological characteristics different from that of human influenza A virus as well as that of influenza B virus.


Subject(s)
Influenza A virus/enzymology , Neuraminidase/metabolism , Colorimetry , Edetic Acid/pharmacology , Epitopes , Fluorometry , Species Specificity , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...